Fierce BioTech
APRIL 16, 2025
Advancing Precision Oncology: Leveraging multidimensional biomarker insights with CGIP for efficient drug development and enhanced patient outcomes scox Wed, 04/16/2025 - 17:44 Thu, 05/29/2025 - 11:00 Resource Type Webinar Taylor Jensen, Ph.D. Precision oncology drug development faces increasing costs and complexity.
PPD
OCTOBER 18, 2023
With the depth of knowledge to support all types of pharmaceutical products across all phases of development, we provide services ranging from end-to-end assay development to platform expansion, designed with the client’s timeline and budget in mind. Stay ahead of the curve with a great GMP/CMC contract laboratory partner.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
APRIL 7, 2025
GPCRs are critical targets for drug development due to their involvement in numerous disease pathologies, with many medications working by either activating or inhibiting these receptors. 2022) Why 90% of clinical drug development fails and how to improve it?, References Sun D, et al. doi:10.1016/j.apsb.2022.02.002.
PerkinElmer
NOVEMBER 12, 2020
In drug development, assays are test systems that gauge the effects of chemical compounds on certain cellular, molecular, or biochemical processes. They are a vital step in modern pharma research that pushes drugs to market faster. These are just three of the steps to take toward reliable and replicable assay development.
Alta Sciences
AUGUST 21, 2023
Efficient Characterization of ADME A critical feature of the bioanalytical platform selected for a drug development program is how well it characterizes the ADME (absorption, distribution, metabolism, excretion) of your molecule of interest. Why Partner With Altasciences for Your Bioanalytical Projects?
Drug Target Review
NOVEMBER 1, 2023
We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production. In 2019 he became Reader in Structural Biology and Cancer Drug Discovery. Although we are an academic centre we work very much like industry.
Sygnature Discovery
JANUARY 17, 2023
About SB Drug Discovery SB Drug Discovery is an industry leader in specialist contract research, providing critical data for novel drug development through cell line generation, assay development and compound screening services. SB is based in Glasgow and employs 55 people.
Expert insights. Personalized for you.
52 
Let's personalize your content